Our instruments can perform one of the most common hematology tests, the complete blood count (CBC), a quantitative test that counts the number of various white blood cells, red blood cells and platelets in human and animal blood. A CBC test is important because it can evaluate one’s overall state of health and is used to diagnose several disorders, including anemia, infections and leukemia. For this reason, hematology analyzers are an essential part of every laboratory.

Norma was among the first companies to utilize microfluidic technologies (the blood samples used for the measurement pass through hairline tubes inside the device) in the development of hematology analyzers, which allowed us to develop the smallest hematology analyzers with the smallest sample volume processing and smallest reagent consumption in the world.

Our innovations enable the analyzers to be used in point-of-care or near-patient testing environments, such as in Intensive Care Units, Emergency Departments, General Practitioner Offices, Blood Banks, Mobile Care Units. Since the launch of our company, Norma has acquired several patents and awards, from which the most outstanding were the International Red Dot Design Award in 2014, the Hungarian Millennium Innovation Award in 2016 and the Environmental Innovation Prize in 2018.

Our Vision

Our vision is to make hematology practices available in every corner of the world. We continuously focusing on creating new technologies that can contribute to a more effective patient care by allowing patients to receive quicker diagnosis and treatment at site, thus helping them with more efficient and faster recovery.

Our Mission

Our mission is to be the leading point-of-care or near-patient hematology manufacturer in the world.

Norma Instruments Zrt. products

Hematology Reagents

Norma-iRP - Reagent Packs